Jubilant Pharmova Limited — Updates, 01-10-2025: General Updates
01-10-2025 | 01:19 pm
01-10-2025 | 01:19 pm
Jubilant Biosys Limited (JBL), a subsidiary, completed the API business acquisition. The company allotted ₹515.59 Cr in preference shares and paid ₹80 Cr cash, making the total consideration for the API business ₹595.59 Cr.
No comments yet. Be the first to comment!
